|Dr. Jonathan Simons, director of Emory University's Winship Cancer Institute, today announced that Paul Doetsch, PhD, has been named Associate Director for Basic Research for the Winship Cancer Institute.
Dr. Doetsch, currently Professor of Biochemistry, Radiation Oncology and Hematology & Oncology at Emory University School of Medicine, will remain an active laboratory investigator as well as assume Emory University leadership responsibilities for more than 70 laboratory based faculty. Dr. Doetsch is internationally recognized for his studies in the area of DNA damage, repair and genetic instability in eukaryotic systems. He is the author of over 90 scientific publications and has an extensive track record of service on editorial boards, NIH and American Cancer Society study sections and national and international scientific committees.
"We are delighted that Dr. Doetsch will formally join the Winship senior leadership team as Associate Director for Basic Research," said Dr. Simons. "He and his colleagues were the first to discover and report the existence of transcriptional mutagenesis in living cells, a pathway that is likely to be involved in a host of profoundly important biological processes ranging from cellular adaptation to stressful environments to tumor development. In addition, he has been an important architect in the development of innovative, cross-disciplinary scientific collaborations at Emory."
Dr. Doetsch earned a PhD in biochemistry from Temple University School of Medicine in Philadelphia. He conducted his post-doctoral work in biochemistry and molecular biology at Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School in Boston.
For more than 20 years, Dr. Doetsch's laboratory work has focused on the biochemistry, molecular biology and genetics of DNA damage and repair in eukaryotes as well as the interaction of the transcriptional machinery with DNA damage in cancer cells. In addition, a recent area of interest is the interconnection between different DNA repair and damage processing pathways and the relationship to genomic instability.
"The future of cancer research is very bright at Emory," said Dr. Doetsch, "and I look forward to playing a significant role in the Winship Cancer Institute's development into an NCI-designated Comprehensive Cancer Center."